Cidara Therapeutics (NASDAQ:CDTX) Earns Buy Rating from Needham & Company LLC
Needham & Company LLC reaffirmed their buy rating on shares of Cidara Therapeutics (NASDAQ:CDTX – Free Report) in a report issued on Friday morning,Benzinga reports. Needham & Company LLC currently has a $35.00 price objective on the biotechnology company’s stock. A number of other research firms also recently commented on CDTX. Citizens Jmp began coverage […]
Needham & Company LLC reaffirmed their buy rating on shares of Cidara Therapeutics (NASDAQ:CDTX – Free Report) in a report issued on Friday morning,Benzinga reports. Needham & Company LLC currently has a $35.00 price objective on the biotechnology company’s stock. A number of other research firms also recently commented on CDTX. Citizens Jmp began coverage […]
